Trial Profile
Cardiac monitoring beyond first dose in relapsing remitting Multiple Sclerosis patients treated with Fingolimod to identify adverse effects on atrioventricular conduction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Nov 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 25 Nov 2016 New trial record